- Home
- PLPC vs PHAR Comparison
PLPC vs PHAR Comparison
Compare PLPC & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLPC
- PHAR
- Stock Information
- Founded
- PLPC 1947
- PHAR 1988
- Country
- PLPC United States
- PHAR Netherlands
- Employees
- PLPC N/A
- PHAR N/A
- Industry
- PLPC Water Sewer Pipeline Comm & Power Line Construction
- PHAR Biotechnology: Pharmaceutical Preparations
- Sector
- PLPC Industrials
- PHAR Health Care
- Exchange
- PLPC Nasdaq
- PHAR Nasdaq
- Market Cap
- PLPC 695.1M
- PHAR 624.1M
- IPO Year
- PLPC N/A
- PHAR N/A
- Fundamental
- Price
- PLPC $134.32
- PHAR $8.86
- Analyst Decision
- PLPC
- PHAR Strong Buy
- Analyst Count
- PLPC 0
- PHAR 3
- Target Price
- PLPC N/A
- PHAR $27.00
- AVG Volume (30 Days)
- PLPC 41.3K
- PHAR 5.9K
- Earning Date
- PLPC 03-06-2025
- PHAR 03-13-2025
- Dividend Yield
- PLPC 0.60%
- PHAR N/A
- EPS Growth
- PLPC N/A
- PHAR N/A
- EPS
- PLPC 6.65
- PHAR N/A
- Revenue
- PLPC $572,200,000.00
- PHAR $285,745,000.00
- Revenue This Year
- PLPC N/A
- PHAR $20.08
- Revenue Next Year
- PLPC N/A
- PHAR $9.22
- P/E Ratio
- PLPC $20.21
- PHAR N/A
- Revenue Growth
- PLPC N/A
- PHAR 30.64
- 52 Week Low
- PLPC $109.01
- PHAR $6.65
- 52 Week High
- PLPC $154.90
- PHAR $12.20
- Technical
- Relative Strength Index (RSI)
- PLPC 42.47
- PHAR 48.50
- Support Level
- PLPC $139.19
- PHAR $8.50
- Resistance Level
- PLPC $143.03
- PHAR $9.50
- Average True Range (ATR)
- PLPC 4.12
- PHAR 0.56
- MACD
- PLPC -1.33
- PHAR 0.03
- Stochastic Oscillator
- PLPC 0.06
- PHAR 58.71
About PLPC Preformed Line Products Company
Preformed Line Products Co is a designer and manufacturer of products and systems for constructing and maintaining overhead and underground networks for energy, telecommunication, cable operators, data communication, and other industries. In addition, it provides solar hardware systems and mounting hardware for a variety of solar power applications. Its products consist of Energy Products, Communications Products, and Special Industries Products. The company's majority of the revenue is derived from the sale of products in The Americas with operations also in PLP-USA, Europe, the Middle East and Africa, and Asia-Pacific. The revenue gets driven by Energy products which comprise protecting transmission conductors, spacers, spacer-dampers, and Stockbridge dampers.
About PHAR Pharming Group N.V.
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.